TGAオーストラリア供給不足情報（4月29日～5月5日更新分）

ホーム > 供給不足情報 > 海外医薬品不足状況 > オーストラリア > TGAオーストラリア供給不足情報（4月29日～5月5日更新分）
Active ingredientsDosage formQuantity of active ingredientsShortage statusSupply impact start dateAvailabilityReasonLast updated
paracetamol~codeine phosphate hemihydrate~doxylamine succinateTablet, uncoated450 mg~30 mg~5 mgResolved2/05/2024AvailableManufacturing6/05/2024
fluoxetine hydrochlorideCapsule, hard22.36 mgAnticipated13/05/2024AvailableManufacturing6/05/2024
gliclazideTablet, modified release30 mgCurrent20/10/2023Limited AvailabilityManufacturing6/05/2024
silver sulfadiazineCream10 mg/gCurrent31/01/2024UnavailableManufacturing6/05/2024
betamethasone sodium phosphate~betamethasone acetateInjection, suspension3.9 mg/mL~3 mg/mLCurrent1/02/2023Limited AvailabilityProduct recall6/05/2024
rosuvastatin calcium~ezetimibeTablet~Tablet, film coated10.396 mg~10 mgCurrent26/03/2024Limited AvailabilityManufacturing6/05/2024
cisplatinInjection, concentrated1 mg/mLCurrent9/04/2024UnavailableUnexpected increase in consumer demand6/05/2024
cisplatinInjection, concentrated1 mg/mLCurrent9/04/2024UnavailableUnexpected increase in consumer demand6/05/2024
rosuvastatin calciumTablet, film coated5.21 mgCurrent26/04/2024Limited AvailabilityManufacturing6/05/2024
thiotepaInjection, powder for100 mgCurrent3/05/2024UnavailableUnexpected increase in consumer demand6/05/2024
ketoprofenCapsule, modified release185.8 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability6/05/2024
cisplatinInjection, solution1 mg/mLCurrent2/04/2024Limited AvailabilityManufacturing6/05/2024
ethinylestradiol~norethisteroneTablet, uncoated36 microgram~1 mgCurrent26/04/2024Limited AvailabilityManufacturing6/05/2024
amoxicillin trihydrateOral Liquid, powder for114.82 mg/mLCurrent29/07/2022UnavailableManufacturing6/05/2024
Interferon beta1aInjection, solution88 microgram/mLDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability5/05/2023
estradiol hemihydrateDrug delivery system, transdermal3.09 mgCurrent23/04/2024Limited AvailabilityUnexpected increase in demand due to other sponsors unable to supply5/05/2024
bupivacaine hydrochloride monohydrateInjection, solution52.7 mgResolved11/03/2024AvailableUnexpected increase in consumer demand3/05/2024
hydrochlorothiazide~enalapril maleateTablet, uncoated6 mg~20 mgCurrent23/03/2021UnavailableManufacturing3/05/2024
diazoxideInjection, solution15 mg/mLAnticipated1/08/2024AvailableTransport / Logistic issues / Storage capacity issues3/05/2024
betahistine dihydrochlorideTablet, uncoated16 mgCurrent28/07/2023UnavailableManufacturing3/05/2024
fentanyl citrateTablet.4713 mgCurrent4/04/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues3/05/2024
metformin hydrochlorideTablet, film coated500 mgCurrent10/01/2024UnavailableManufacturing3/05/2024
Insulin lisproInjection, solution100 IU/mLCurrent3/05/2024Limited AvailabilityManufacturing3/05/2024
cefalexin monohydrateSuspension, powder for26.288 mg/mLCurrent13/01/2023Limited AvailabilityManufacturing3/05/2024
nifedipineTablet, modified release60 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability3/05/2023
bortezomibInjection, powder for3.5 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability2/05/2024
duloxetine hydrochlorideCapsule, enteric33.7 mgCurrent29/04/2024Limited AvailabilityManufacturing2/05/2024
duloxetine hydrochlorideCapsule, enteric67.3 mgAnticipated15/08/2024AvailableManufacturing2/05/2024
Insulin glargineInjection, solution3.6378 mg/mLAnticipated14/06/2024AvailableManufacturing2/05/2024
silver sulfadiazineCream10 mg/gCurrent31/01/2024UnavailableManufacturing2/05/2024
levetiracetamTablet, film coated1000 mgAnticipated12/07/2024AvailableTransport / Logistic issues / Storage capacity issues2/05/2024
montelukast sodiumTablet, chewable5.2 mgCurrent20/03/2024UnavailableManufacturing2/05/2024
montelukast sodiumTablet, chewable4.16 mgCurrent9/01/2024UnavailableManufacturing2/05/2024
levetiracetamTablet, film coated500 mgResolved13/12/2023AvailableManufacturing2/05/2024
carmustineInjection, powder for100 mgAnticipated30/05/2024AvailableManufacturing2/05/2024
quetiapine fumarateTablet, modified release460.52 mgCurrent19/04/2024UnavailableTransport / Logistic issues / Storage capacity issues2/05/2024
paracetamolInjection, solution10 mg/mLCurrent1/03/2024Limited AvailabilityUnexpected increase in consumer demand2/05/2024
quetiapine fumarateTablet, film coated115.12 mgResolved8/12/2023AvailableManufacturing2/05/2024
escitalopram oxalateTablet, film coated25.548 mgCurrent26/04/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues2/05/2024
lisinopril dihydrateTablet, uncoatedQSCurrent12/04/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues2/05/2024
lisinopril dihydrateTablet, uncoatedQSCurrent29/03/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues2/05/2024
paracetamolInjection, solution10 mg/mLCurrent20/02/2024UnavailableUnexpected increase in consumer demand2/05/2024
pemetrexed disodiumInjection, powder for1102.9 mgCurrent30/04/2024UnavailableUnexpected increase in demand due to other sponsors unable to supply2/05/2024
Follitropin alfaInjection, solution300 IUResolved2/02/2024AvailableManufacturing2/05/2024
irbesartan~hydrochlorothiazideTablet, film coated300 mg~25 mgResolved3/04/2024AvailableManufacturing2/05/2024
lidocaine hydrochlorideInjection, solution400 mgCurrent14/06/2023Limited AvailabilityManufacturing2/05/2024
insulinInjection, suspension100 IU/mLCurrent23/10/2023Limited AvailabilityManufacturing2/05/2024
octreotideInjection, solution100 microgram/mLCurrent1/02/2024Limited AvailabilityUnexpected increase in demand due to other sponsors unable to supply2/05/2024
famotidineTablet, film coated20 mgCurrent10/08/2023Limited AvailabilityManufacturing2/05/2024
famotidineTablet, film coated40 mgCurrent10/08/2023Limited AvailabilityManufacturing2/05/2024
lisinopril dihydrateTablet, uncoated10.89 mgAnticipated4/10/2024AvailableTransport / Logistic issues / Storage capacity issues1/05/2024
methotrexateInjection, solution1000 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability1/05/2023
bupivacaine hydrochloride monohydrateInjection, solution52.8 mgResolved25/09/2023AvailableManufacturing1/05/2024
acetylcholine chlorideSolution, powder for irrigation10 mg/mLCurrent15/09/2023UnavailableTransport / Logistic issues / Storage capacity issues1/05/2024
midazolamInjection, solution5 mg/mLResolved8/04/2024AvailableTransport / Logistic issues / Storage capacity issues1/05/2024
sodium fluorideInjection, concentrated1 mg/mLCurrent30/11/2023UnavailableManufacturing1/05/2024
valganciclovirSolution, powder for5 gResolved22/03/2024AvailableManufacturing1/05/2024
rocuronium bromideInjection, solution50 mgCurrent18/12/2023UnavailableManufacturing1/05/2024
donepezil hydrochlorideTablet, film coated10 mgAnticipated26/07/2024AvailableTransport / Logistic issues / Storage capacity issues1/05/2024
levetiracetamTablet, film coated250 mgAnticipated16/08/2024AvailableTransport / Logistic issues / Storage capacity issues1/05/2024
imatinib mesilateTablet, film coated478 mgResolved25/01/2024AvailableManufacturing1/05/2024
primaquine phosphateTablet, uncoated13.2 mgResolved1/04/2024AvailableManufacturing1/05/2024
olmesartan medoxomilTablet40 mgCurrent1/03/2024UnavailableUnexpected increase in consumer demand1/05/2024
pregabalinCapsule, hard150 mgCurrent30/01/2024Limited AvailabilityManufacturing1/05/2024
imatinib mesilateTablet, film coated478 mgCurrent15/03/2024UnavailableManufacturing1/05/2024
irbesartan~hydrochlorothiazideTablet, film coated300 mg~12.5 mgResolved14/07/2023AvailableManufacturing1/05/2024
tadalafilTablet5 mgCurrent29/01/2024UnavailableUnexpected increase in demand due to other sponsors unable to supply1/05/2024
imatinib mesilateTablet, film coated119.5 mgCurrent10/04/2024Limited AvailabilityManufacturing1/05/2024
atorvastatin calcium trihydrateTablet, film coated10.845 mgAnticipated5/07/2024AvailableTransport / Logistic issues / Storage capacity issues1/05/2024
cinacalcet hydrochlorideTablet, film coated66 mgCurrent20/12/2023UnavailableManufacturing1/05/2024
carbetocinInjection, solution100 microgramCurrent11/12/2023UnavailableManufacturing1/05/2024
atorvastatin calcium trihydrate~ezetimibeTablet, film coated41.363 mg~10 mgCurrent24/04/2024Limited AvailabilityManufacturing1/05/2024
ezetimibe~atorvastatin calcium trihydrateTablet, film coated10 mg~20.681 mgCurrent24/04/2024Limited AvailabilityManufacturing1/05/2024
ezetimibe~atorvastatin calcium trihydrateTablet, film coated10 mg~41.363 mgAnticipated31/05/2024AvailableManufacturing1/05/2024
hydrochlorothiazide~amlodipine besilate~olmesartan medoxomilTablet, film coated25 mg~6.95 mg~40 mgCurrent31/07/2023UnavailableManufacturing1/05/2024
prasugrelTablet, film coated10 mgCurrent11/04/2024Limited AvailabilityManufacturing1/05/2024
metformin hydrochlorideTablet, modified release500 mgResolved10/04/2024AvailableManufacturing1/05/2024
colchicineTablet, uncoated500 microgramResolved1/04/2024AvailableManufacturing1/05/2024
flucloxacillin sodium monohydrateInjection, powder for1088.1 mgCurrent29/02/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues1/05/2024
methylphenidate hydrochlorideTablet, modified release27 mgCurrent20/02/2024UnavailableTransport / Logistic issues / Storage capacity issues1/05/2024
flecainide acetateTablet50 mgAnticipated15/05/2024AvailableManufacturing1/05/2024
rosuvastatin calcium~ezetimibeTablet10.4 mg~10 mgCurrent15/03/2024UnavailableManufacturing1/05/2024
rosuvastatin calcium~ezetimibeTablet~Tablet, film coated20.8 mg~10 mgCurrent30/01/2024UnavailableManufacturing1/05/2024
mycophenolate sodiumTablet, enteric coated384.8 mgCurrent27/03/2024UnavailableManufacturing1/05/2024
folic acid~riboflavine sodium phosphate~cyanocobalamin~thiamine nitrate~pyridoxine hydrochloride~Biotin~nicotinamide~sodium ascorbate~sodium pantothenateInjection, powder for.4 mg~4.9 mg~5 microgram~3.1 mg~4.9 mg~60 microgram~40 mg~113 mg~16.5 mgCurrent30/04/2024Limited AvailabilityManufacturing1/05/2024
naproxenTablet, uncoated250 mgCurrent22/04/2024Limited AvailabilityManufacturing1/05/2024
mupirocin calciumCream20.7683 mg/gCurrent22/04/2024Limited AvailabilityUnexpected increase in consumer demand1/05/2024
midazolamInjection, solution5 mg/mLCurrent29/04/2024Limited AvailabilityManufacturing1/05/2024
diazepamTablet, uncoated5 mgCurrent2/02/2024Limited AvailabilityManufacturing1/05/2024
metformin hydrochlorideTablet, film coated500 mgCurrent26/04/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues1/05/2024
Vibrio cholerae~Vibrio choleraeOral Liquid, suspension31.25 billion organisms~1 mgResolved18/12/2023AvailableManufacturing1/05/2024
cilastatin~imipenemInjection, powder for500 mg~500 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability30/04/2024
paclitaxelInjection, concentrated6 mg/mLResolved29/02/2024AvailableManufacturing30/04/2024
amlodipine besilateTablet, uncoated6.9335 mgCurrent11/04/2024UnavailableManufacturing30/04/2024
fluoxetine hydrochlorideCapsule, hard22.36 mgCurrent10/01/2024UnavailableManufacturing30/04/2024
fentanylDrug delivery system, transdermal1.28 mgCurrent24/04/2024Limited AvailabilityCommercial Changes / Commercial viability30/04/2024
clonidine hydrochlorideTablet, uncoated100 microgramCurrent18/03/2024Limited AvailabilityManufacturing30/04/2024
ropivacaine hydrochlorideInjection, solution150 mgResolved2/04/2024AvailableTransport / Logistic issues / Storage capacity issues30/04/2024
codeine phosphate hemihydrate~paracetamol~promethazine hydrochlorideOral Liquid, solution1 mg/mL~24 mg/mL~1.3 mg/mLDiscontinuedReduction in supply until supply is exhaustedManufacturing30/04/2024
epirubicin hydrochlorideInjection, concentrated200 mgCurrent9/04/2024Limited AvailabilityManufacturing30/04/2024
rifampicinCapsule300 mgResolved17/10/2023AvailableManufacturing30/04/2024
rosuvastatin calciumTablet, film coated41.68 mgCurrent24/03/2023UnavailableCommercial Changes / Commercial viability30/04/2024
rosuvastatin calciumTablet, film coated10.42 mgCurrent1/01/2024Limited AvailabilityManufacturing30/04/2024
pregabalinCapsule, hard75 mgCurrent24/03/2023UnavailableCommercial Changes / Commercial viability30/04/2024
tranexamic acidTablet, film coated500 mgCurrent18/03/2024UnavailableManufacturing30/04/2024
lisdexamfetamine dimesilateCapsule, hard40 mgResolved22/01/2024AvailableUnexpected increase in consumer demand30/04/2024
lisdexamfetamine dimesilateCapsule, hard60 mgResolved18/12/2023AvailableManufacturing30/04/2024
hydrochlorothiazide~olmesartan medoxomilTablet12.5 mg~40 mgResolved1/07/2023AvailableManufacturing30/04/2024
solifenacin succinateTablet, film coated5 mgCurrent1/11/2023UnavailableManufacturing30/04/2024
solifenacin succinateTablet, film coated10 mgCurrent1/12/2023UnavailableManufacturing30/04/2024
amlodipine besilate~olmesartan medoxomilTablet, film coated6.935 mg~20 mgCurrent1/02/2024UnavailableManufacturing30/04/2024
suxamethonium chloride dihydrateInjection, solution100 mgResolved28/03/2023AvailableTransport / Logistic issues / Storage capacity issues30/04/2024
isotretinoinCapsule, soft10 mgCurrent6/12/2023UnavailableManufacturing30/04/2024
isotretinoinCapsule, soft20 mgCurrent24/01/2024UnavailableManufacturing30/04/2024
deferasiroxTablet, film coated360 mgCurrent16/10/2023Emergency Supply OnlyManufacturing30/04/2024
pegcetacoplanInjection, solution1080 mgAnticipated15/05/2024AvailableManufacturing30/04/2024
olmesartan medoxomil~amlodipine besilateTablet, film coated40 mg~6.94 mgCurrent30/04/2024Limited AvailabilityUnexpected increase in consumer demand30/04/2024
lidocaine hydrochloride monohydrateInjection, solution20 mg/mLAnticipated1/06/2024AvailableManufacturing30/04/2024
estradiol hemihydrateDrug delivery system, transdermal1.54 mgCurrent29/04/2024Limited AvailabilityUnexpected increase in demand due to other sponsors unable to supply30/04/2024
aciclovirInjection, solution25 mg/mLCurrent28/07/2023UnavailableUnexpected increase in demand due to other sponsors unable to supply30/04/2024
diltiazem hydrochlorideCapsule, modified release240 mgResolved21/11/2022AvailableManufacturing30/04/2024
estradiol hemihydrateDrug delivery system, transdermal2.32 mgCurrent29/04/2024UnavailableUnexpected increase in demand due to other sponsors unable to supply30/04/2024
chlorhexidine gluconateSolution, irrigation30 mgAnticipated1/06/2024AvailableManufacturing29/04/2024
ropivacaine hydrochlorideInjection, solution20 mgCurrent26/04/2024Limited AvailabilityTransport / Logistic issues / Storage capacity issues29/04/2024
mercaptopurine monohydrateOral Liquid, suspension20 mg/mLAnticipated31/05/2024AvailableManufacturing29/04/2024
amlodipine besilateTablet13.87 mgResolved12/04/2024AvailableManufacturing29/04/2024
naloxone hydrochloride dihydrateSpray, nasal2.2 mg/actuationResolved11/03/2024AvailableTransport / Logistic issues / Storage capacity issues29/04/2024
hydrocortisone acetateEnema10 % w/wCurrent1/01/2018UnavailableManufacturing29/04/2024
sodium chlorideInjection, solution90 mgAnticipated31/05/2024AvailableManufacturing29/04/2024
captoprilTablet, uncoated25 mgCurrent30/06/2023UnavailableManufacturing29/04/2024
captoprilTablet, uncoated50 mgCurrent19/12/2023UnavailableManufacturing29/04/2024
cefaclor monohydrateOral Liquid, powder for52.45 mg/mLAnticipated10/05/2024AvailableManufacturing29/04/2024
2024年5月6日
このページの先頭へ戻る